Streptococcal Infections

Total Page:16

File Type:pdf, Size:1020Kb

Streptococcal Infections CHAPTER 34 Streptococcal Infections Barry M. Gray 1. Introduction coccus is now a separate genus but will be considered an honorary streptococcus in this chapter because of its sim­ The streptococci are a large heterogeneous group of gram­ ilarities to enteric streptococci. The enterococcus is part of positive spherically shaped bacteria found widely distrib­ the normal bowel flora and has been increasingly isolated uted in nature. They include some of the most important as an opportunistic invader, especially in nosocomial in­ agents of human disease, as well as members of the fections (see Chapter 25). This chapter will focus mainly normal human flora. Some streptococci have been associ­ on group A and B streptococci and will include current ated mainly with disease in animals, while others have information on pneumococci and other streptococci asso­ been domesticated and used for the culture of buttermilk, ciated with human disease. Further details on S. pneu­ yogurt, and certain cheeses. Those known to cause human moniae may be found in Chapter 28. disease can be thought of as comprising two broad catego­ ries: First are the pyogenic streptococci, including the familiar [3-hemolytic streptococci and the pneumococcus. 2. Historical Background These organisms are not generally part of the normal flora but cause acute, often severe, infections in normal hosts. Streptococcal infections were recognized by Greek Second are the more diverse enteric and oral streptococci, physicians by the 3rd century B.C. A description of which are nearly always part of the normal flora and which erysipelas is recorded in Epidemicus and attributed to are more frequently associated with opportunistic infec­ Hippocrates. In the Middle Ages, scarlet fever, or "scar­ tions. latina," as it was called in Italy, was an eye-catching and Measured in terms of mortality, morbidity, and eco­ notable disease. Sydenham's description in 1676 clearly nomic costs, five streptococcal species are of major im­ differentiated this disease from measles and other rashes, portance in human disease. (1) The group A streptococcus, but it was not until 1924 that G.F. and G.H. Dick showed Streptococcus pyogenes, produces a wide range of infec­ conclusively that streptococci were the causative agents. tions, from pharyngitis and impetigo to puerperal sepsis Until the advent of penicillin, childbed fever, or puerperal and erysipelas. Their non suppurative sequelae include sepsis, remained one of the most frequent causes of death acute rheumatic fever and acute glomerulonephritis. among otherwise healthy young women. The classic (2) The group B streptococcus, S. agalactiae, is currently works of Holmes, in 1858, and Semmelweis, in 1861, a leading cause of sepsis in newborn infants and a frequent described the transmission of this disease and provided cause of postpartum infections in mothers. (3) The pneu­ guidelines for effective preventive measures that are still mococcus, S. pneumoniae, remains the most frequent applicable today. Rheumatic fever was first described by cause of bacterial pneumonia in all age groups and is a Wells in 1812, and Bouillaud described the association of common agent in otitis media, bacteremia, and men­ acute rheumatism and heart disease in 1835. In 1836, ingitis. (4) Among the oral streptococci, S. mutans is Bright published his account of "renal disease accom­ important as a principal agent of dental caries. (5) Entero- panied with secretion of albuminous urine."(l) Osler pro­ vided detailed descriptions of "malignant scarlet fever," Barry M. Gray • Division of Medical Education, Spartanburg Re­ which remained common until the advent of antibiotics gional Medical Center, Spartanburg, South Carolina 29303. (see Fig. 1). Severe invasive disease, including necrotizing 673 A. S. Evans et al. (eds.), Bacterial Infections of Humans © Springer Science+Business Media New York 1998 674 Part II • Acute Bacterial Infections 7000 14 c 0 :;::: 6000 !! Scarlet Fever - Number of Deaths 12 ::s .- Q. II) l 0 .c 5000 i a.. (IJ '\ \ 10 -Q) !i 0 C :: 0 '\ 0 4000 .... \ 0 .... 0 - , 8 0,.. "- Q) V \ ... .c 3000 \ Q) E :: 6 Q. ::s \ Z Q) 2000 \ ...4~ 4 (IJ Streptococcal Sore Throat ~- VI Nurrber of Deaths .c 1000 2 (IJ 50"'" F,,,,,,- -Q) D'~h R~'~ C III' ·........ t 0 ............. 0 1905 1915 1925 1935 1945 1955 1965 1975 Recorded Data 1910-1940 Resident Data 1940-1975 Figure 1. The number of deaths (left-hand scale) from scarlet fever (1900-1960) and from all streptococcal sore throat (1950-1975), with death rates (right-hand scale) per 100,000 population in the United States. Appropriate comparability ratios were applied beginning in 1940, and recorded data compiled according to the geographic locale where the event occurred without regard to residence (1900-1940); resident data were compiled according to the usual place of residence without regard to locale where the event occurred (1940-1975). The population used for determining rates was that of the registration area. Data were not available for streptococcal sore throat for 1900-1950. The number of states reporting for 1900-1905 was 10, gradually increasing to 48 in 1935 and to 50 states in 1960. After 1975, reporting was optional, and no accurate data are available. Sources of data: US Bureau of the Census, Historical Statistics of the United States: Colonial Times to 1970, Bicentennial ed., Part I, p. 77, 1975; National Office of Vital Statistics, Vital Statistics Reports, Vol. 37, No.9 (1920-1950); Centers for Disease Control, Morbidity and Mortality Weekly Report, Annual Supplement, 1960 and 1970. Figure redrawn from Quinn.(l) fasciitis, "hemolytic streptococcus gangrene," and myo­ descriptive value than the term "S. haemolyticus," which sitis, was much less common and did not appear in the was commonly used through the early part of this century. medical literature until the second and third decades of The formal classification of streptococci began when this century. During the mid-1970s to 1980s, cases of acute blood agar came into use and the hemolytic properties of rheumatic fever and acute glomerulonephritis became ex­ various organisms were noted. In 1919, Brown used the ceedingly rare (see Fig. 2), and streptococcal disease term "beta" to describe streptococci that produced a 2- to seemed only an inconvenience. By the late 1980s, how­ 4-mm zone of clear hemolysis around colonies grown on ever, rheumatic fever made a dramatic reappearance, blood agar. "Alpha" streptococci were those producing along with an increase in severe invasive infections and incomplete, greenish hemolysis. Most of the isolates from the emergence of a streptococcal toxic shock syn­ severe human disease were f3-hemolytic. It was not until dromep-4) Group A streptococci made the headline in the 1928, when Lancefield introduced methods of serotyping popular press as "killer strep," the "flesh-eating bacte­ streptococci based on immunologic reactions with cellu­ ria. " lar components, that groups and types within groups could In the late 19th century, many investigators contrib­ be clearly distinguished. The group antigens were eventu­ uted to the understanding of streptococci and their relation ally shown to be specific cell wall carbohydrates. The to human disease. By the 1880s many species had been group A streptococci were further differentiated by the M given names such as S. epidemicus, S. erysipelatus, S. and T protein antigens. The f3-hemolytic streptococci scarlatinae, and S. rheumaticus, which reflected different from most human infections proved to be those of group manifestations of streptococcal infection. The name S. A. Armed with these new epidemiological tools, Lance­ pyogenes dates from this period but is probably of less field and Hare(5) investigated cases of puerperal sepsis Chapter 34 • Streptococcal Infections 675 Number of Positive Number of Cases Throat Cultures __ Rheumatic Fever ......... Glomerulonephritis 8000 40 7000 35 6000 30 5000 25 4000 20 3000 15 2000 10 1000 5 o+-~~-,~~~~~~~~~~~~~~~~~-+o 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 YEAR Figure 2. The number of positive throat cultures (left-hand scale and number of confirmed cases of rheumatic fever and acute glomerulonephritis (right-hand scale) seen in private pediatirc practices participating in streptococcal surveillance studies in Rochester, New York, 1967-1988. The data were kindly provided by Caroline Breese Hall, University of Rochester. at Queen Charlotte's Hospital in London, beginning in the nized as perinatal pathogens for over 20 years. Rather, early 1930s. Of 46 cases of postpartum sepsis, all but one there seems to have been a real increase in group B isolate was group A, and the exception was identified as disease, beginning in the United States and Europe during the prototype of a new serological group, designated the 1960s. By the mid-1970s, numerous reports of group B group G. A year earlier, Hare and Colebrook observed that disease appeared in the literature, and the group B strep­ hemolytic streptococci resembling those associated with tococcus was said to have come of age'<6,7) sepsis were never found in vaginal cultures of healthy The pneumococcus has an interesting and important women, but that some women carried streptococci that history, beginning with its association with pneumonia resembled those isolated in bovine mastitis. The latter and later with developments in immunization and serum organisms proved to be members of streptococcus group therapy (see Chapter 28). Studies of the pneumococcus
Recommended publications
  • Infection Control in Dentistry: How to Asepsis Photographic Mirrors?
    Infection control in dentistry: how to asepsis photographic mirrors? Amanda Osório Ayres de Freitas* Mariana Marquezan* Giselle Naback Lemes Vilani* Rodrigo César Santiago* Luiz Felipe de Miranda Costa* Sandra Regina Torres** Abstract: The aim of this study was to evaluate the efficacy of six different methods of disinfection and sterilization of intra­oral photographic mirrors through microbiological testing and to analysis their potential harm to mirrors’ surface. Fourteen occlusal mirrors were divided into seven groups. Group 1 comprised two mirrors as received from manufacturer. The other six groups comprised mirrors disinfected/sterilized by autoclave, immersion in enzymatic detergent, and friction with chlorhexidine detergent, chlorhexidine wipes, common detergent and 70% ethylic alcohol. Microbiological and quality surface analyses were performed. Sterilization in autoclave was microbiologic effective, but caused damage to the mirror surface. Chlorhexidine (in wipes or detergent) and liquid soap were effective disinfectant agents for photographic mirrors decontamination, without harmful effect on its surface. Enzymatic detergent immersion and friction with 70% ethylic alcohol were not effective as disinfectant agents for photographic mirrors decontamination. According to the results, the more effective and safe methods for photographic mirrors disinfection were friction with chlorhexidine wipes or detergent, as well as liquid soap. Results, the most efficacious methods for photographic mirrors disinfection were friction with chlorhexidine wipes and detergent, as well as common detergent. Descriptors: Dental Instruments; Decontamination; Microbiology; Surface Properties. *Doutoranda em Odontologia na Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil **Pós­doutora em odontologia pela University of Washington (UW), Seattle, WA, Estados Unidos ISSN 2236­5843 │ 93 Introduction Dental photography is an important tool for diagnostic and treatment planning, and it’s also a registration of the patient’s condition before and after treatment.
    [Show full text]
  • ANTT Guidelines
    www.antt.org ANTT Guidelines The ANTT Clinical Guideline for the Preparation & Administration of Peripheral and Central Intravenous Medications (IV Therapy) Rationale and supporting evidence ANTT IV Prep and Administration V3 .0 2013 The Association for Safe Aseptic Technique (ASAP) www.antt.org www.antt .org ® © 2013 Aseptic Non Touch Technique (ANTT) This document is a publication of The-ASAP and all rights of copyright, intellectual property and Trademark are reserved. ANTT is protected to prevent dilution and misrepresentation of the practice framework so as to avoid ANTT becoming another unhelpful generic term for aseptic technique that is variably interpreted. For guidance see [email protected]. This document may however, be freely reviewed, copied and translated, in part, or in whole, for LOCAL, SINGLE ORGANIZATION educational use. It must not be published via the www/internet or its content used for production and publication of dedicated ANTT e-learning resources. ANTT is not for sale or for use in conjunction with commercial purposes. The-ASAP provide a number of free core ANTT resources to help disseminate and train healthcare staff. The- ASAP requests that the balance it determines between free dissemination and protection of the standard is respected in the interests of patient safety. Disclaimer: The-ASAP provides the ANTT Clinical Practice Framework and ANTT Clinical Guidelines to healthcare organizations in good faith in a collaboration to promote effective aseptic technique. It is the responsibility of healthcare organizations to implement ANTT effectively. No guarantee or responsibility for the application or outcome of clinical practice can be, or is, assumed or accepted by The-ASAP/ANTT.
    [Show full text]
  • Medical Laboratory Assistant, a Suggested Guide for A
    p .7/ tWI .7- y,1.. P O R T R ESUM ED 013 321 VT 002 2L4 MEDICAL LABORATORY ASSISTANT, A SUGGESTEDGUIDE FOR A TRAINING PROGRAM. OFFICE OF EDUCATION, WASHINGTON, D.C. REPORT NUMBER 0E-87017 PUB DATE 66 EDRS PRICE MF-$0.50 HC-$4.92 123P. DESCRIPTORS-. *MEDICAL LABORATORY ASSISTANTS,TEACHING GUIDES, *PROGRAM PLANNING, PROGRAM DEVELOPMENT,*CURRICULUM GUIDES, CURRICULUM, *HEALTH OCCUPATIONSEDUCATION, POST SECONDARY EDUCATION, MDTA PROGRAMS, INFORMATION IS GIVEN TO ASSIST IN ORGANIZINGAND ADMINISTERING A TRAINING PROGRAM FOR MEDICAL LABORATORY ASSISTANTS IN A VARIETY OF SETTINGS AND TO PROVIDEGUIDANCE IN ESTABLISHING NEW PROGRAMS AND IN EVALUATINGEXISTING ONES. THE MATERIAL WAS PREPARED UNDER THE DIRECTIONOF THE NATIONAL COMMITTEE =OR CAREERS IN MEDICAL TECHNOLOGY.PATHOLOGISTS AND MEDICAL TECHNOLOGISTS PARTICIPATEDIN THE ORGANIZATIONAL AND DEVELOPMENTAL STAGES. ALL MATERIAL WAS REVIEWEDBY A REPRESENTATIVE NATIONAL GROUP OF EXPERTCONSULTANTS IN THE FIELD OF LABORATORY MEDICINE. THE 12-MONTH PROGRAM WAS DESIGNED FOR HIGH SCHOOL GRADUATES OR THEIREQUIVALENT TO SE ADMINISTERED BY A TEACHING STAFF COMPOSEDOF A NATIONAL DIRECTOR, A. TEACHING SUPERVISOR, ANDINSTRUCTORS. AN OUTLINE OF INFORMATIONAL MATERIAL TO BE PRESENTEDIN THE CLASSROOM, LABORATORY PROCEDURES TO BE DEMONSTRATEDAND THEN PERFORMED AS DIRECT EXERCISES BY THE STUDENTS, AS WELLAS RELEVANT BIBLIOGRAPHIES, AUDIOVISUAL AIDS, AND STUDYQUESTIONS ARE PRESENTED FOR THE FOLLOWING UNITS (1) ORIENTATION TO THE CLINICAL LABORATORY,(2) BACTERIOLOGY,(3) SEROLOGY, (4) PARASITOLOGY,(5) HEMATOLOGY, (6) CLINICAL CHEMISTRY,(7) BLOOD BANKING,(8) ROUTINE ANALYSIS, AND (9) BASAL METABOLISM -- ELECTROCARDIOGRAPHY. THIS DOCUMENT IS AVAILABLE AS GPO NUMBER FS 5.267-07017 FOR 60 CENTS FROMSUPERINTENDENT OF DOCUMENTS, U.S. GOVERNMENT PRINTING OFFICE,WASHINGTON, D.C. 20402. (PS) cir 02281"2=10.
    [Show full text]
  • Module 6: Principles of Asepsis
    Module 6: Medical and Surgical Asepsis Module 6: Medical and Surgical Asepsis Minimum Number of Theory Hours: 2 Suggested Theory Hours: 5 Recommended Clinical Hours: 8 Statement of Purpose: The purpose of this unit is to present information about asepsis and the control of infection. Procedures and precautions to protect patient/patients/residents, health care workers and others from infection are presented, including standard precautions, transmission- based precautions and biohazardous waste management. Terminology 1. Acquired Immunodeficiency 21. Escherichia coli (E. coli) 40. Non-intact Syndrome (AIDS) 22. Excretions 41. Nosocomial 2. Airborne precautions 23. Exposure incident 42. Occupational Safety and Health 3. Asepsis 24. Flora Administration (OSHA) 4. Athlete’s foot 25. Fungus 43. Pathogens 5. Bacteria 26. Health Care-Associated Infection 44. Personal Protective Equipment 6. Barriers (HAI) (PPE) 7. Biohazard symbol 27. Hepatitis A, B, C, D, E 45. Pneumonia 8. Bloodborne 28. Herpes zoster 46. Precautions 9. Carrier spore 29. Host 47. Protozoa 10. Centers for Disease Control (CDC) 30. Immunity 48. Reservoir 11. Chain of infection 31. Infection 49. Reverse isolation 12. Communicable 32. Infectious agent 50. Rickettsia 13. Contact precautions 33. Influenza 51. Scabies 14. Contagious microbes 34. Isolation 52. Sepsis 15. Contamination 35. Lice 53. Standard precautions 16. Disinfection 36. Material Safety Data Sheet (MSDS) 54. Sterilization 17. Disorientation 37. Methicillin-Resistant 55. Streptococcus 18. Disposable Staphylococcus
    [Show full text]
  • The Efficacy of Three Hand Asepsis Techniques Using Chlorhexidine Gluconate (Chg 2%)
    A RTIGO Eficácia de três métodos de degermação das mãos utilizando gluconato de clorexidina O degermante (GCH 2%) RIGINAL THE EFFICACY OF THREE HAND ASEPSIS TECHNIQUES USING CHLORHEXIDINE GLUCONATE (CHG 2%) EFICACIA DE TRES MÉTODOS DE DESINFECCIÓN DE LAS MANOS UTILIZANDO GLUCONATO DE CLORHEXIDINA ANTISÉPTICA (GHC 2%) Érika Rossetto da Cunha1, Fabiana Gonçalves de Oliveira Azevedo Matos2, Adriana Maria da Silva3, Eutália Aparecida Cândido de Araújo4, Karine Azevedo São Leão Ferreira5, Kazuko Uchikawa Graziano6 RESUMO ABSTRACT RESUMEN A degermação cirúrgica das mãos e dos The scrubbing of hands and forearms using La desinfección quirúrgica de manos y an- antebraços é um procedimento que inte- anti septi c agents has been the standard pre- tebrazos es un procedimiento que integra gra as ati vidades de paramentação cirúr- operati ve procedure to prevent surgical site las acti vidades prequirúrgicas como me- gica como uma medida de prevenção de infecti on. With the introducti on of anti sep- dida de prevención contra infección del infecção do síti o cirúrgico. Com o advento ti c agents, the need to use brushes for pre- siti o quirúrgico. Con el advenimiento de la dos princípios anti ssépti cos degermantes, operati ve disinfecti on has been questi oned anti sepsia desinfectante, se cuesti ona y se a necessidade do uso de escovas para a and it has been recommended that the pro- recomienda dejar de lado el uso de cepillos degermação cirúrgica tem sido questi ona- cedure be abandoned due to the injuries it debido a lesiones provocadas en piel. Para da e recomendado o abandono deste uso may cause to the skin.
    [Show full text]
  • Summary ANTIMICROBIAL AGENTS
    ANTIMICROBIAL AGENTS Summary of a Round Table Discussion By Mark H. Lepper, M.D., and Harris D. Riley, Jr., M.D. Department of Preventive Medicine, University of Illinois (M.H.L.), and Department of Pediatrics, University of Oklahoma (H.D.R.) NTIMKROBIAL agents have had an espe- sistance of the host to infection. (The effect cially great impact in pediatrics. Al- of cortisone on stneptococcal infections in though many diseases have been conquered the rabbit was cited : 58 out of 66 rabbits easily with proper antimicrobial therapy, pnetreated with cortisone died; 5 of 60 con- there still remain difficulties and failures. trol animals died.) Instances of empyema Dr. Leppen opened the session with a dis- developing during treatment of pneuimo- cussion of some of the failures of antimi- coccal pneumonia with both antibiotics and crobial therapy. ACTH were described. The discussants agreed that at no time should adrenal con- HYPERACUTE INFECTIONS ticosteroids be used in the treatment of in- Hyperacute infections, i.e., infections fectious processes without simultaneoums ad- which are often fatal within 24 hours from ministration of adequate amounts of appro- the onset of symptoms, and resistant strains pniate antibiotics. of organisms, account for the vast majority Dr. Lepper reviewed some of the salient of failures in the use of antibiotics. A few facts in connection with the use of cortisone cases cannot be classified into either cate- and allied substances in the treatment of gory and remain as unexplained failures. overwhelming infections, including menin- The magnitude of the problem of hypen- gococcemia and the Waterhouse-Fnidenich- acute infections can be judged by the fact sen syndrome.
    [Show full text]
  • El Paso Community College Syllabus Part II Official Course Description
    MLAB 2434; Revised Fall 2019/Spring 2020 El Paso Community College Syllabus Part II Official Course Description SUBJECT AREA Medical Laboratory Technology COURSE RUBRIC AND NUMBER MLAB 2434 COURSE TITLE Clinical Microbiology COURSE CREDIT HOURS 4 3 : 4 Credits Lec Lab I. Catalog Description Provides instruction in the theory, practical application, and pathogenesis of clinical microbiology, including collection, quality control, quality assurance, lab safety, setup, identification, susceptibility testing, and reporting results. A grade of "C" or better is required in this course to take the next course. Corequisite: MLAB 2360. (3:4). Lab fee. II. Course Objectives A. Unit I. Introduction to Medical Microbiology 1. State general safety rules for handling pathogenic cultures and potentially infective clinical specimens, to include: a. the importance of personal cleanliness, frequent handwashing, and not putting pens and pencils in the mouth. b. the importance of wearing a lab coat to protect clothing from contamination. c. the importance of keeping personal articles such as books, coats, handbags, etc., off of bench areas. d. reporting all spills of infectious materials and the proper method of cleaning up infectious spills. e. reporting all spills of hazardous materials and the proper method of cleaning up hazardous spills. f. the importance of not eating, drinking, smoking, or applying cosmetics in the laboratory. g. the importance of not wearing open sandals in the laboratory. h. the importance of proper trash disposal--separating paper trash from infectious materials and disposing of infectious materials only in specially marked biohazard bags and paper trash in the regular trash cans. i. reporting any cut or accident involving infectious material, no matter how small.
    [Show full text]
  • Blood Culture Sampling Policy for Adult and Paediatric Patients
    Blood Culture Sampling Policy for Adult and Version: 7.0 Paediatric Patients Date Issued: 25 July 2018 Review Date: 30 May 2021 Document Type: Policy Contents Page Paragraph Executive Summary / Policy Statement / Flowchart 2 1 Scope and Purpose 2 2 Definitions 2 3 Indications for taking a blood culture and procedure 4 4 Roles and Responsibilities 7 5 Related Trust Policies 8 6 Implementation (including training and dissemination) 8 7 Process for Monitoring Compliance/Effectiveness of 9 this Policy 8 Arrangements for Review of this Policy 9 9 References 9 Appendices Page Appendix A List of equipment needed for peripheral blood culture 10 sampling Appendix B ANTT clinical guideline for Blood Culture Sampling 10 Appendix C ANTT clinical guideline for Blood Culture Sampling 10 from a CVC Device without a Transducer Appendix D ANTT clinical guideline for Blood Culture Sampling 10 from a CVC Device with a Transducer Appendix E Paediatric ANTT guideline for Blood Culture Sampling 10 from a CVC device Document Status This is a controlled document. Whilst this document may be printed, the electronic version posted on the intranet is the controlled copy. Any printed copies of this document are not controlled. As a controlled document, this document should not be saved onto local or network drives but should always be accessed from the intranet. Page 1 of 11 Executive Summary Blood cultures are used to detect the cause of a bloodstream infection. The result provides a guide to the appropriate treatment of the patient. False positives may occur if micro- organisms from a site outside of the bloodstream are introduced into the sample of blood obtained for culture which can then result in inappropriate antibiotic therapy and a waste of healthcare resources.
    [Show full text]
  • Medical Asepsis, Hand Hygiene, and Patient Care Practices in Home Care and Hospice Objectives
    Module F MEDICAL ASEPSIS, HAND HYGIENE, AND PATIENT CARE PRACTICES IN HOME CARE AND HOSPICE OBJECTIVES • Describe the principles and practice of asepsis • Understand hand hygiene • Understand the role of the environment in disease transmission DEFINING ASEPSIS Medical Asepsis Surgical Asepsis Definition Clean Technique Sterile Technique Emphasis Freedom from most Freedom from all pathogenic pathogenic organisms organisms Purpose Reduce transmission of Prevent introduction of any pathogenic organisms from organism into an open one patient‐to ‐another wound or sterile body cavity MEDICAL ASEPSIS Measures aimed at controlling the number of microorganisms and/or preventing or reducing the transmission of microbes from one person‐to‐another: Clean Technique • Know what is dirty • Know what is clean • Know what is sterile • Keep the first three conditions separate • Remedy contamination immediately PRINCIPLES OF MEDICAL ASEPSIS When the body is penetrated, natural barriers such as skin and mucous membranes are bypassed, making the patient susceptible to microbes that might enter. • Perform hand hygiene and put on gloves • When invading sterile areas of the body, maintain the sterility of the body system • When placing an item into a sterile area of the body, make sure the item is sterile PRINCIPLES OF MEDICAL ASEPSIS Even though skin is an effective barrier against microbial invasion, a patient can become colonized with other microbes if precautions are not taken. • Perform hand hygiene between patient contacts • When handling items that only touch patient’s intact skin, or do not ordinarily touch the patient, make sure item is clean and disinfected (between patients). PRINCIPLES OF MEDICAL ASEPSIS All body fluids from any patient should be considered contaminated • Body fluids can be the source of infection for the patient and you • Utilize appropriate personal protective equipment (PPE) • When performing patient care, work from cleanest to dirtiest patient area.
    [Show full text]
  • Dairy and Food Sanitation 1984-12
    ISSN:0273-2866 .kTtversitv microfilms December, 1984 Box 701 ROAD Vol. 4. No. 12 Ames, Iowa 50010 SSn arbor mi Pages 461-500 48106 $5.00 APubltcMtlonofthmlntmmmttonmlAaaoclmbon of MUk. food and Bivironmfitml Sanitmrimns, Inc 504131^' A Suspected Waterborne Spice Quality in Illness Outbreak Clear Plastic Packaging Food Irradiation Continuous Culture Course at UC Fermenters Used In Davis, March 13-15 Im Study of Ruminant Nutritionm ACDPI Student Essay Deadline is January 15 National Mastitis Council Meeting, February 15-17, 1985 Call for Research Papers for the 1985 Annual Meeting. See the October Issue. Which of the three NSF service areas can best help you? If your product, system, service, Assessment Services or job responsibility is in any This group undertakes special way relat^ to public health and testing, research, demonstra¬ the environment, there’s a tion projects, and studies for strong possibility NSF can help industry, service companies, you. We offer a distinct trio of government, and individuals service areas: Listing, Certifi¬ with health and environmental cation aond Assessment. And concerns. A report is published our totally professional staff but no seal or logo is issued. can, and does, provide you with Take advantage of NSF’s straight answers, laboratory Free! Write ftw: unique expertise and capabili¬ testing, on-site inspections, in- Facts about Certification Services; Facts about Assessment Services; ties, group problem solving depth research, and on-going Facts about Listing Services; approach and reputation for education to help you meet Facts about NSF. objectivity. your public responsibilities. In all three service areas we dard may display the NSF are known and respected as an Listing Services round blue seal or logo and ap¬ objective third-party, and we The Foundation’s long-standing pear in an annual Listing.
    [Show full text]
  • Prevention of Hospital-Acquired Infections World Health Organization
    WHO/CDS/CSR/EPH/2002.12 Prevention of hospital-acquired infections A practical guide 2nd edition World Health Organization Department of Communicable Disease, Surveillance and Response This document has been downloaded from the WHO/CSR Web site. The original cover pages and lists of participants are not included. See http://www.who.int/emc for more information. © World Health Organization This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors. The mention of specific companies or specific manufacturers' products does no imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. WHO/CDS/CSR/EPH/2002.12 DISTR: GENERAL ORIGINAL: ENGLISH Prevention of hospital-acquired infections A PRACTICAL GUIDE 2nd edition Editors G. Ducel, Fondation Hygie, Geneva, Switzerland J. Fabry, Université Claude-Bernard, Lyon, France L. Nicolle, University of Manitoba, Winnipeg, Canada Contributors R. Girard, Centre Hospitalier Lyon-Sud, Lyon, France M. Perraud, Hôpital Edouard Herriot, Lyon, France A. Prüss, World Health Organization, Geneva, Switzerland A. Savey, Centre Hospitalier Lyon-Sud, Lyon, France E. Tikhomirov, World Health Organization, Geneva, Switzerland M. Thuriaux, World Health Organization, Geneva, Switzerland P. Vanhems, Université Claude Bernard, Lyon, France WORLD HEALTH ORGANIZATION Acknowledgements The World Health Organization (WHO) wishes to acknowledge the significant support for this work from the United States Agency for International Development (USAID).
    [Show full text]
  • ANTT Guidelines
    www.antt .org ANTT Guidelines The ANTT Clinical Guideline for Blood Culture Collection Rationale and supporting evidence 1 ANTT: Blood Culture Collection v2.0 2013 The Association for Safe Aseptic Practice www.antt.org © 2013 Aseptic Non Touch Technique (ANTT)® This document is a publication of The-ASAP and all rights of copyright, intellectual property and Trademark are reserved. ANTT is protected to prevent dilution and misrepresentation of the practice framework so as to avoid ANTT becoming another unhelpful generic term for aseptic technique that is variably interpreted. For guidance see [email protected]. This document may however, be freely reviewed, copied and translated, in part, or in whole, for LOCAL, SINGLE ORGANIZATION educational use. It must not be published via the www/internet or its content used for production and publication of dedicated ANTT e-learning resources. ANTT is not for sale or for use in conjunction with commercial purposes. The-ASAP provide a number of free core ANTT resources to help disseminate and train healthcare staff. The- ASAP requests that the balance it determines between free dissemination and protection of the standard is respected in the interests of patient safety. Disclaimer: The-ASAP provides the ANTT Clinical Practice Framework and ANTT Clinical Guidelines to healthcare organizations in good faith in a collaboration to promote effective aseptic technique. It is the responsibility of healthcare organizations to implement ANTT effectively. No guarantee or responsibility for the application or outcome of clinical practice can be, or is, assumed or accepted by The-ASAP/ANTT. Published by The Association for Safe Aseptic Practice (ASAP) ANTT: Blood Culture Collection v2.0 2013 The Association for Safe Aseptic Practice www.antt.org 2 Glossary Please note: Historically, the terms below have been defined variously and often ambiguously in the medical literature.
    [Show full text]